LINC01942

Across TCGA pan-cancer cohorts, LINC01942 RNA differs between tumor and matched normal tissue in 11 of 18 cancer types tested, making tumor–normal expression one of LINC01942’s most consistent transcriptional readouts.

The strongest signal is observed in thyroid carcinoma (THCA), where LINC01942 RNA is repressed in tumor relative to normal tissue. In most cancer types LINC01942 is over-expressed in tumor, although a few such as THCA and LUSC show the opposite, repressed pattern.

THCA, LUSC, and COAD are the cancer types where LINC01942 tumor–normal differential expression is most reproducible.

RNA tumor vs normal associations by lineage

Ranked by sampling consensus. Fold-change is the tumor-versus-normal difference in LINC01942 RNA (log₂); positive values indicate higher expression in tumor. p-values are from the differential-expression test.

Lineage	Gender	Stage	Fold-change	p	Sampling consensus
THCA	Male	IV	−0.279	<.001	9	view →
LUSC	Female	All	−0.828	<.001	8	view →
COAD	Female	II,III,IV	+0.546	<.001	7	view →
LIHC	Male	All	+0.790	<.001	6	view →
BRCA	All	II,III,IV	−0.557	<.001	6	view →
KICH	All	All	−0.875	<.001	4	view →
UCEC	All	All	−0.448	.018	4	view →
STAD	All	All	+0.338	.003	3	view →
LUAD	All	IV	−0.700	.032	2	view →
READ	Female	All	+0.642	.002	2	view →
PRAD	All	All	−0.133	.008	2	view →

Pink = over-expressed in tumor, green = repressed in tumor. Showing the 11 strongest of 11 lineages.

LINC01942–THCA

Open the THCA breakdown →